Home/Tiziana Life Sciences/Ivor Elrifi

IE

Ivor Elrifi

Chief Executive Officer

Tiziana Life Sciences

Therapeutic Areas

Neurodegenerative Diseases Neuroinflammatory Diseases Lung Diseases

Tiziana Life Sciences Pipeline

Drug	Indication	Phase
Foralumab (intranasal)	Non-Active Secondary Progressive Multiple Sclerosis	Phase 2
TZLS-501	Lung Diseases	Preclinical
Milciclib	NSCLC (pan-KRAS+)	Preclinical

Leadership Team at Tiziana Life Sciences

Howard L. Weiner, M.D.

Chairman of the Scientific Advisory Board

View full Tiziana Life Sciences profile